A 14-week, Double-blind, Randomized, Three-arm, Parallel Group Study to Assess the Efficacy and Safety of Two Doses of Pridopidine Versus Placebo for the Treatment of Levodopa-induced Dyskinesia in Patients With Parkinson's Disease (gLIDe)

July 15, 2019
https://clinicaltrials.gov/ct2/show/NCT03922711
Parkinson Disease
Principal Investigator: Neepa J Patel, MD

Parkinson's disease, Parkinson's, Parkinson

Accepting Participants
(248)661-6540